Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Hypogonadism

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   43881   clinical trials with a EudraCT protocol, of which   7295   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    87 result(s) found for: Hypogonadism. Displaying page 1 of 5.
    1  2  3  4  5  Next»
    EudraCT Number: 2007-005640-25 Sponsor Protocol Number: Tostran2v1 Start Date*: 2008-05-08
    Sponsor Name:Greater Glasgow & Clyde Health Board
    Full Title: Effect of Tostran 2% Gel on Growth, Development & Bone Turnover in Hypogonadal Adolescent Boys
    Medical condition: Delayed puberty or hypogonadism in boys requiring pubertal induction.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10021011 Hypogonadism male LLT
    9.1 10043335 Testicular hypogonadism LLT
    9.1 10052649 Primary hypogonadism LLT
    9.1 10059594 Secondary hypogonadism LLT
    9.1 10059597 Central hypogonadism LLT
    9.1 10014692 Endocrine abnormalities of puberty HLT
    9.1 10012205 Delayed puberty LLT
    Population Age: Adolescents, Under 18 Gender: Male
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-005200-13 Sponsor Protocol Number: A-94-00500-004 Start Date*: 2007-08-09
    Sponsor Name:Ipsen Pharma GmbH
    Full Title: Phase II multi-centre, randomised, open, comparative study of the safety and efficacy of transdermal testosterone (Testim®) compared to intramuscular testosterone depot for the induction of puberty...
    Medical condition: Delayed puberty due to central (hypogonadotrophic) or peripheral (hypergonadotrophic) hypogonadism
    Disease: Version SOC Term Classification Code Term Level
    9.1 10021011 Hypogonadism male LLT
    Population Age: Adolescents, Under 18, Adults Gender: Male
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2007-001690-28 Sponsor Protocol Number: 22978379 Start Date*: 2007-09-12
    Sponsor Name:Dept of Endocrinology, Odense University Hospital
    Full Title: Odense Androgen Study - The effect of Testim vs strength training i a populationbased, randomised, placebocontrolled, doubleblinded study in hypogonadal men
    Medical condition: This study will prodvide information on the Metabolic syndrome and the relationship with hypogonadism in older men.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10021011 Hypogonadism male LLT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2008-001060-36 Sponsor Protocol Number: MTE08 Start Date*: 2008-09-05
    Sponsor Name:Acrux Pharma Pty Ltd
    Full Title: A Phase III open-label titration trial to evaluate the effectiveness and safety of different doses of a dermal application of Testosterone MD-Lotion® (cutaneous solution) in hypogonadal men
    Medical condition: Male Hypogonadism
    Disease: Version SOC Term Classification Code Term Level
    9.1 10021011 Hypogonadism male LLT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: GB (Completed) DE (Completed) SE (Completed) FR (Completed)
    Trial results: View results
    EudraCT Number: 2009-017139-16 Sponsor Protocol Number: Bay 86-5037/14853 Start Date*: 2010-06-10
    Sponsor Name:Bayer HealthCare AG
    Full Title: Effect of exercise alone or in combination with testosterone replacement on muscle strength and quality of life in older men with low testosterone concentrations: a randomized double-blind, placebo...
    Medical condition: The objective of this study is to determine whether in older men with symptomatic age-associated testosterone deficiency exercise training in combination with testosterone replacement therapy leads...
    Disease: Version SOC Term Classification Code Term Level
    12.1 10021011 Hypogonadism male LLT
    Population Age: Elderly Gender: Male
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2020-002140-22 Sponsor Protocol Number: Vitality Start Date*: 2020-11-02
    Sponsor Name:Lars møller Pedersen
    Full Title: Gonadal dysfunction in male long-term survivors of malignant lymphoma
    Medical condition: Hypogonadism
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004860 10043335 Testicular hypogonadism LLT
    Population Age: Adults Gender: Male
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2017-001012-11 Sponsor Protocol Number: NAT-2017-01 Start Date*: 2017-08-01
    Sponsor Name:Acerus Biopharma Inc.
    Full Title: A multicenter, open label, variable dose, two arm pilot paediatric phase 1 PK study to evaluate testosterone nasal gel (4.5% w/w) in hypogonadal boys
    Medical condition: Primary and secondary hypogonadism
    Disease: Version SOC Term Classification Code Term Level
    20.0 10014698 - Endocrine disorders 10052649 Primary hypogonadism PT
    20.0 10014698 - Endocrine disorders 10059594 Secondary hypogonadism PT
    Population Age: Adolescents, Under 18 Gender: Male
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2012-000291-42 Sponsor Protocol Number: TEST-DM1 Start Date*: 2012-10-05
    Sponsor Name:Consorci Mar Parc de Salut de Barcelona (Parc de Salut Mar)
    Full Title: Effect of treatment with testosterone undecaonat in patients with Diabetes Mellitus Type 1 (DM-1) and hipogonadotrophic hypogonadism
    Medical condition: Diabetes Mellitus Type 1 (DM-1) and hipogonadotrophic hypogonadism
    Disease:
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2019-004677-12 Sponsor Protocol Number: RHYTHM Start Date*: 2021-02-09
    Sponsor Name:UNIVERSITA' DEGLI STUDI DI MODENA E REGGIO EMILIA - DIPARTIMENTO DI SCIENZE BIOMEDICHE, METABOLICHE E NEUROSCIENZE
    Full Title: Pharmacodynamics and safety of human recombinant luteinising hormone in hypogonadotropic hypogonadal men.
    Medical condition: Aquired hypogonadotropic hypogonadism
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004860 10021012 Hypogonadotrophic hypogonadism LLT
    Population Age: Adults Gender: Male
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2008-002053-20 Sponsor Protocol Number: DC00065/91579 Start Date*: 2008-09-15
    Sponsor Name:Bayer Healthcare AG
    Full Title: A 54 week treatment, randomized, multi center, double blind, placebo controlled study to assess the safety and efficacy of NEBIDO 1000 mg (4 ml) in elderly men with symptomatic late onset hypogonad...
    Medical condition: Symptomatic late onset hypogonadism
    Disease: Version SOC Term Classification Code Term Level
    9.1 10021011 Hypogonadism male LLT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: LV (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2006-002304-33 Sponsor Protocol Number: no sponsor Start Date*: 2006-09-12
    Sponsor Name:Rijnstate Hospital
    Full Title: Letrozole Treatment to Normalize Serum Testosterone in Men with Hypogonadotropic Hypogonadism due to Pituitary Damage.
    Medical condition: Hypogonadotropic hypogonadism in men with pituitary damage other than irradiation
    Disease: Version SOC Term Classification Code Term Level
    8.1 10021012 Hypogonadotrophic hypogonadism LLT
    Population Age: Adults Gender: Male
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2012-001258-25 Sponsor Protocol Number: MK8962-031-00 Start Date*: 2012-11-29
    Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
    Full Title: A phase III, multi-center, open label, uncontrolled trial to investigate the efficacy and safety of MK-8962 (corifollitropin alfa) in combination with human Chorionic Gonadotropin (hCG) in inducing...
    Medical condition: Hypogonadotropic hypogonadism (HH) in males may result from either absent or inadequate gonadotropin-releasing hormone (GnRH) secretion by the hypothalamus or failure of pituitary gonadotropin secr...
    Disease: Version SOC Term Classification Code Term Level
    16.1 100000004860 10021012 Hypogonadotrophic hypogonadism LLT
    Population Age: Adults Gender: Male
    Trial protocol: DE (Completed) ES (Completed) IT (Completed) GB (Completed) PL (Completed) Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2014-002155-25 Sponsor Protocol Number: TAK-448-2001 Start Date*: 2014-11-17
    Sponsor Name:Takeda Development Centre Europe Ltd
    Full Title: An Open-Label, Phase 2a Study to Evaluate the Pharmacodynamics of Different Dosing Regimens of TAK-448, a Kisspeptin Agonist, in Male Overweight/Obese Subjects With Hypogonadotropic Hypogonadism
    Medical condition: Hypogonadotropic Hypogonadism
    Disease: Version SOC Term Classification Code Term Level
    18.1 100000004860 10021012 Hypogonadotrophic hypogonadism LLT
    Population Age: Adults Gender: Male
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2012-004866-16 Sponsor Protocol Number: I5E-MC-TSAT Start Date*: 2013-06-06
    Sponsor Name:Eli Lilly and Company
    Full Title: A Randomized, Double-Blind, Placebo-Controlled Parallel Study with an Open-Label Extension to Assess the Impact of Testosterone Solution on Total Testosterone, Sex Drive and Energy in Hypogonadal Men.
    Medical condition: Male hypogonadism
    Disease: Version SOC Term Classification Code Term Level
    14.1 10014698 - Endocrine disorders 10021011 Hypogonadism male PT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: DE (Completed) IT (Completed) GB (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2013-001734-17 Sponsor Protocol Number: FuMA Start Date*: 2014-04-23
    Sponsor Name:University of Rome Foro Italico
    Full Title: Short-term effects of testosterone enhantate and gel on neuro-physiological function
    Medical condition: HYPOGONADISM
    Disease: Version SOC Term Classification Code Term Level
    16.1 10014698 - Endocrine disorders 10058359 Hypogonadism PT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2014-004729-42 Sponsor Protocol Number: 22102014 Start Date*: 2015-04-13
    Sponsor Name:Odense University Hospital, department M [...]
    1. Odense University Hospital, department M
    2. Odense University Hospital
    Full Title: The effect of testosterone replacement in patients with hypogonadotroph hypogonadism due to opioid treatment for non-malignant disease A double-blinded, randomized and placebo-controlled trial
    Medical condition: Male Hypogonadism
    Disease: Version SOC Term Classification Code Term Level
    17.1 100000004860 10021012 Hypogonadotrophic hypogonadism LLT
    Population Age: Adults Gender: Male
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2020-002612-52 Sponsor Protocol Number: LUCAS Start Date*: 2021-02-19
    Sponsor Name:Department of Endocrinology, Rigshospitalet
    Full Title: A randomized, double-blinded, clinical, placebo-controlled trial on the effects of therapy with Letrozole and hUman Choriongonadotropin in male hypogonadism induced by illicit use of Anabolic andro...
    Medical condition: Male hypogonadism related to illicit use of anabolic androgenic steroids
    Disease: Version SOC Term Classification Code Term Level
    20.0 10014698 - Endocrine disorders 10058359 Hypogonadism PT
    21.0 10038604 - Reproductive system and breast disorders 10021926 Infertility PT
    Population Age: Adults Gender: Male
    Trial protocol: DK (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2010-021268-13 Sponsor Protocol Number: Letrozole2010-1 Start Date*: 2010-11-19
    Sponsor Name:University College Dublin
    Full Title: The Effects of Normalising Sex Hormone Levels in Obese Hypogonadal Men: A Prospective Randomized Comparator Controlled Parallel Arm Clinical Trial
    Medical condition: Obesity Related Male Hypogonadism
    Disease: Version SOC Term Classification Code Term Level
    12.1 10029883 Obesity LLT
    12.1 10021011 Hypogonadism male LLT
    Population Age: Adults Gender: Male
    Trial protocol: IE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2004-004891-36 Sponsor Protocol Number: L00074TD301 Start Date*: 2005-04-01
    Sponsor Name:PIERRE FABRE MEDICAMENT
    Full Title: CROSS-OVER COMPARISON OF TESTOSTERONE SERUM LEVELS IN HYPOGONADAL MEN TREATED WITH L0074 TESTOSTERONE PATCH 60CM2 (2 patches/48H) AND ORAL TESTOSTERONE UNDECANOATE -PANTESTONE® 40mg- (2 caps, bid)
    Medical condition: Men aged > 18 years old with primary or secondary hypogonadism. Only patients meeting the inclusion criteria will be enrolled in this study.
    Disease: Version SOC Term Classification Code Term Level
    7.1 10021011 PT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2008-001459-23 Sponsor Protocol Number: D Box 2008/0000 Start Date*: 2008-06-24
    Sponsor Name:Nikolai Sleep Monitoring Clinic
    Full Title: Treatment of Testosterone deficiency in men with Sleep Apnoea Syndrome utilising Nebido therapy.
    Medical condition: Sleep Apnoea Hypogonadism- testosterone deficiency syndrome
    Disease: Version SOC Term Classification Code Term Level
    9.1 10021011 Hypogonadism male LLT
    9.1 10040977 Sleep apnoea LLT
    Population Age: Adults Gender: Male
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Mon May 20 00:30:36 CEST 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA